PTC Therapeutics (United States)
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for PTC Therapeutics (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
49%
Total
Publications
383
Total Open
Publications
189
Total
Citations
12K
Open Access
Percentage
49%
Total
Publications
383
Total Open
Publications
189
Total
Citations
12K
Breakdown
Publisher Open
13%
Both
28%
Other Platform Open
8%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 24%
37
Hybrid 51%
80
No Guarantees 25%
40
Other Platform Open
Domain 86%
121
Institution 18%
25
Public 13%
18
Other Internet 13%
18
Preprint 10%
14
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 122 |
Europe PMC | Domain | 63 |
University College London - UCL Discovery | Institution | 19 |
Figshare | Public | 13 |
California Digital Library - eScholarship | Other Internet | 11 |
bioRxiv | Preprint | 10 |
Semantic Scholar | Public | 9 |
DOI | Other Internet | 7 |
University of Massachusetts Medical School - eScholarship@UMMS | Institution | 6 |
Research Square | Preprint | 6 |